Tilkal is a Paris-based company founded in 2017 that specializes in developing a software platform for traceability across supply chains. Its end-to-end, real-time traceability solution integrates permissioned blockchain networks with big data to facilitate secure and verifiable data sharing among various supply chain stakeholders. The platform allows businesses to record traceability data of physical products in a ledger, enhancing compliance, transparency, and consumer trust. Tilkal's technology is actively utilized by major corporations such as Groupe Casino and Danone, providing them with the tools to analyze traceability data, manage sourcing risks, and demonstrate environmental, social, and governance (ESG) commitments. By focusing on resilience, sustainability, and ethical practices, Tilkal aims to improve the overall integrity of supply chains across diverse industries.
Ganymed Robotics SAS, a medical device company, focuses on the development of robotics technologies for orthopedic surgeons. It develops a therapeutic device to enhance surgical precision in knee replacement surgery. The company was incorporated in 2018 and is based in Paris, France.
Qubit Pharmaceuticals, incorporated in 2020 and based in Paris, France, develops innovative technology aimed at enhancing pharmaceutical drug discovery. The company offers a drug discovery simulation platform that reduces the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, Qubit's platform conducts virtual screening and visualization to identify promising drug candidates. This approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
Connecting Food is a foodtech company based in Paris, France, that specializes in a blockchain-based platform for real-time tracking and auditing of food products. Established in 2016, the company offers LiveAudit, an application that allows digital auditing of product quality throughout the entire production process. This platform enables consumers, particularly those purchasing eggs, to access detailed information about the hen's breed, the farm of origin, and the packing location. By leveraging blockchain technology, Connecting Food provides a transparent supply chain solution that fosters trust among farmers, manufacturers, retailers, and consumers, thereby enhancing brand equity and ensuring the integrity of agricultural and finished products.
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies. The company uses proprietary gene editing and plant biotechnology to drastically reduce the cost of making growth factors. The growth factors are molecules used in the clean meat and cell therapy industries.
Scipio Bioscience is a biotechnology company based in Paris, France, founded in 2017. The company specializes in manufacturing benchtop kits that serve as a sample preparation solution for single-cell studies. These kits are designed for use in sequencing applications within both clinical and basic research, focusing particularly on transcriptomics. By enabling single-cell barcoding in a test tube format, Scipio Bioscience's products facilitate advanced research in single-cell analysis, supporting laboratories in their scientific endeavors.
EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles. They develop a bioproduction platform to produce extracellular vesicles at a commercial scale in a GMP compliant way for pharmaceutical companies with applications in regenerative medicine and drug delivery. Extracellular vesicles that encompass exosomes, microvesicles, and apoptotic bodies are the tools used by cells to communicate with each other. EVerZom was founded in 2019 and is headquartered in Paris, Ile-de-France, France.
Powder is a startup that helps to share video clips of favorite games, follow people with the same interests and interact with them.
Epigene Labs SAS, founded in 2019 and headquartered in Paris, France, with an additional office in Boston, Massachusetts, develops a biotechnology platform that harnesses advanced artificial intelligence to transform genomic data into actionable insights for precision oncology. The platform addresses the challenges of aggregating, analyzing, and visualizing extensive genomic datasets, which are crucial for advancing precision oncology. By integrating proprietary data from partners with publicly available information, Epigene Labs provides medical researchers with user-friendly analytics and insights that facilitate drug development and research in cancer treatment. The company focuses on forming value-based partnerships with leading cancer centers and prominent biotech firms to enhance the efficacy of oncology solutions.
ThrustMe is a startup emerging from the Laboratoire de Physique des Plasmas at the Ecole Polytechnique and the CNRS, founded by Ane Aanesland and Dmytro Rafalskyi. The company specializes in the development, production, and commercialization of next-generation space propulsion systems utilizing its patented technology. With a focus on simplifying and enhancing the efficiency of electric propulsion, ThrustMe provides tailored solutions for both next-generation satellites and ground testing of space hardware. This approach supports space teams and aerospace businesses in achieving economic and environmental sustainability through advanced propulsion options, addressing the evolving needs of the satellite industry and the growing demand for data and global intelligence.
Qubit Pharmaceuticals, incorporated in 2020 and based in Paris, France, develops innovative technology aimed at enhancing pharmaceutical drug discovery. The company offers a drug discovery simulation platform that reduces the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, Qubit's platform conducts virtual screening and visualization to identify promising drug candidates. This approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.
Oledcomm S.A.S. is a company based in Paris, France, that specializes in the design and manufacture of Li-Fi (light fidelity) network interface devices, which facilitate high-speed wireless data communication. Established in 2005, Oledcomm offers a range of products including Li-Fi routers, hubs, switches, and accessories tailored for various applications such as indoor location services, Internet of Things connectivity, and communication in sectors like telecom, datacom, personal electronics, and industrial markets. Their product lineup includes the GEOLiFi LED router and LiFiNET routers, along with development kits and the LiFiCLOUD platform. Oledcomm's solutions cater to diverse environments including museums, retail spaces, hospitals, offices, and smart cities, emphasizing environmentally friendly wireless communication.
Oledcomm S.A.S. is a company based in Paris, France, that specializes in the design and manufacture of Li-Fi (light fidelity) network interface devices, which facilitate high-speed wireless data communication. Established in 2005, Oledcomm offers a range of products including Li-Fi routers, hubs, switches, and accessories tailored for various applications such as indoor location services, Internet of Things connectivity, and communication in sectors like telecom, datacom, personal electronics, and industrial markets. Their product lineup includes the GEOLiFi LED router and LiFiNET routers, along with development kits and the LiFiCLOUD platform. Oledcomm's solutions cater to diverse environments including museums, retail spaces, hospitals, offices, and smart cities, emphasizing environmentally friendly wireless communication.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
Nestwave SAS, established in 2014 and based in Paris, France, specializes in developing geolocation systems tailored for the Internet of Things (IoT) market. The company provides innovative geolocation solutions that leverage patented hybrid-signal technology to enhance localization accuracy, particularly in challenging indoor and dense urban settings. Nestwave's platform integrates a digital signal processing (DSP) software solution, enabling IoT modem and DSP vendors to incorporate accurate geolocation capabilities into their products. This approach not only improves reliability and accuracy but also minimizes power consumption and reduces the overall footprint of the solution compared to traditional methods.
CorWave SA is a medical device company based in Clichy, France, specializing in the development and manufacture of heart-assist pumps. Founded in 2011, CorWave focuses on innovative technologies to improve patient outcomes in advanced heart failure. Its flagship product, the CorWave Left Ventricular Assist Device (LVAD), employs a unique undulating disc wave pumping mechanism that mimics the natural pulsatile flow of the heart, significantly reducing trauma to the blood and minimizing complications such as clotting and bleeding. This technology contrasts with traditional continuous flow pumps, which lack significant pulsation. Additionally, the company offers Nemo, a minimally invasive cardiac pump designed for patients who are not candidates for LVADs, providing chronic, partial support. CorWave's devices are characterized by low power consumption and compact design, which may enable total implantability with wireless energy transfer systems.
CarThera SAS specializes in the design and development of therapeutic ultrasound-based medical devices aimed at treating brain disorders. Founded in 2010 and headquartered in Paris, France, the company has developed innovative devices such as SonoProbe, which addresses conditions like brain tumors, epilepsy, metastases, and meningioma. Another key product is SonoCloud, an intracranial ultrasound implant that temporarily opens the blood-brain barrier, enhancing the delivery and concentration of therapeutic molecules for the treatment of primary brain tumors. Through these advancements, CarThera is focused on improving treatment outcomes for patients with serious neurological conditions.
CarThera SAS specializes in the design and development of therapeutic ultrasound-based medical devices aimed at treating brain disorders. Founded in 2010 and headquartered in Paris, France, the company has developed innovative devices such as SonoProbe, which addresses conditions like brain tumors, epilepsy, metastases, and meningioma. Another key product is SonoCloud, an intracranial ultrasound implant that temporarily opens the blood-brain barrier, enhancing the delivery and concentration of therapeutic molecules for the treatment of primary brain tumors. Through these advancements, CarThera is focused on improving treatment outcomes for patients with serious neurological conditions.
Altaroad SAS is a French company founded in 2017 that specializes in developing a SaaS-based application for real-time vehicle data capture. The company employs patented nano-sensors embedded in roadways alongside advanced algorithms to analyze and generate critical road data. This technology enables the monitoring of traffic patterns, tracking of vehicle weights, assessment of road impacts, and detection of unsafe driving behaviors. Altaroad's platform supports traffic management in smart cities by identifying maintenance needs, enhancing predictive maintenance for road operators, and facilitating cost savings for logistics providers. Additionally, the system can quickly recognize hazardous conditions, such as icy pavements, and provide feedback for autonomous vehicles, contributing to safer and more efficient road usage.
PKvitality is a bio-wearable company based in Paris, France, founded in 2017. The company has developed K’Track, a line of trackers that utilize its patented SKinTaste technology to analyze physiological markers through non-invasive skin testing, eliminating the need for blood samples. One of its flagship products, K’Watch Glucose, enables diabetic individuals to monitor their glucose levels continuously and conveniently, without the discomfort associated with traditional blood tests. The wearable device features a sensor that requires no calibration, provides a comprehensive data history, and sends alerts to users to remind them to check their glucose levels, enhancing the self-monitoring experience for diabetic patients.
CorWave SA is a medical device company based in Clichy, France, specializing in the development and manufacture of heart-assist pumps. Founded in 2011, CorWave focuses on innovative technologies to improve patient outcomes in advanced heart failure. Its flagship product, the CorWave Left Ventricular Assist Device (LVAD), employs a unique undulating disc wave pumping mechanism that mimics the natural pulsatile flow of the heart, significantly reducing trauma to the blood and minimizing complications such as clotting and bleeding. This technology contrasts with traditional continuous flow pumps, which lack significant pulsation. Additionally, the company offers Nemo, a minimally invasive cardiac pump designed for patients who are not candidates for LVADs, providing chronic, partial support. CorWave's devices are characterized by low power consumption and compact design, which may enable total implantability with wireless energy transfer systems.
Nestwave SAS, established in 2014 and based in Paris, France, specializes in developing geolocation systems tailored for the Internet of Things (IoT) market. The company provides innovative geolocation solutions that leverage patented hybrid-signal technology to enhance localization accuracy, particularly in challenging indoor and dense urban settings. Nestwave's platform integrates a digital signal processing (DSP) software solution, enabling IoT modem and DSP vendors to incorporate accurate geolocation capabilities into their products. This approach not only improves reliability and accuracy but also minimizes power consumption and reduces the overall footprint of the solution compared to traditional methods.
Created in July 2014, Aenitis Technologies is a French start-up resulting from the work of Mauricio HOYOS and Jean-Luc AIDER, both CNRS researchers at the PMMH Laboratory (Physics and Mechanics of Heterogeneous Media at the ESPCI ParisTech, a research engineer’s school in Paris. The company focuses on medical devices’ area, where their breakthrough technologies are highly promising. Aenitis Technologies is developing innovative separation, manipulation and filtration of biological elements solutions, based on acoustophoresis technologies. The company first focuses on technological solutions that will revolutionize current practices in Public Health. Aenitis Technologies aims to become a world leader in filtering / separating solutions by acoustophoresis.